With COLY hovering near cash value and PF-3512676 not completely dead, COLY would seem to be a compelling value play. On the other hand, IDIX is also hovering near cash value and IDIX has an approved drug on the market. No contest, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”